In an ever-changing real estate market, loan originator retention is a key challenge for lenders. Loan officers need faster product rollouts and fewer barriers to focus on core tasks. Leading ...
Biosimilar aflibercept (P041) demonstrated comparable safety and efficacy to the originator aflibercept (Eylea) in treating patients with retinal conditions like neovascular age-related macular ...
Source: Getty Images Researchers found “no significant discrepancy in safety events” between trastuzumab biosimilars and the originator product. Researchers found no significant differences in ...